摘要
Background Although lncRNA TP73-AS1 has been shown to play important roles in various human diseases, its function in atherosclerosis (AS) remains unclear. Methods Human aortic endothelial cells (HAECs) were treated with 50 mu g/ml oxidized low-density lipoprotein (ox-LDL) to establish an atherosclerotic cell model. The expression of TP73-AS1, miR-654-3p and AKT3 was detected by qRT-PCR. Cell functions were evaluated CCK-8 assay and flow cytometry. The protein levels of apoptosis-related proteins were evaluated by western blot. The binding relationship among TP73-AS1, miR-654-3p and AKT3 was determined by bioinformatics analysis and luciferase reporter assay. Results TP73-AS1 was upregulated and miR-654-3p was downregulated in ox-LDL treated HAECs. TP73-AS1 silencing and miR-654-3p mimics decreased the viability and inhibited apoptosis of ox-LDL treated HAECs, decreased the expression levels of c-caspase-9, c-caspase-3 and Bax, and increased Bcl-2 expression. In addition, miR-654-3p inhibitor significantly reversed the inhibitory effects of si-TP73-AS1 on cell viability and apoptosis. TP73-AS1 could positively regulate AKT3 through directly sponging miR-654-3p. Conclusion TP73-AS1 promoted apoptosis of ox-LDL stimulated endothelial cells by targeting the miR-654-3p/AKT3 axis, suggesting that TP73-AS1 might be a potential target for AS treatment.
学科与关键词
- miR-454-3p prevents ox-LDL-induced apoptosis in HAECs by targeting TRPC3Liao, Luming; Yang, Qiaolan; Li, Hailiang; Meng, Rongsen; Li, Yuntian*Experimental and Therapeutic Medicine, 2021, 21(4): 323.被引 6
- Hsa_circ_0030042 Ameliorates Oxidized Low-Density Lipoprotein-Induced Endothelial Cell Injury via the MiR-616-3p/RFX7 AxisYu, Lei; Ma, Wenbin; Song, Binghui; Wang, Shuqing; Li, Xinying; Wang, Zhao*International Heart Journal, 2022, 63(4): 763-772.被引 4
- Possible causes of atherosclerosis: lncRNA COLCA1 induces oxidative stress in human coronary artery endothelial cells and impairs wound healingLi, Ming-Peng; Hao, Zi-Chen; Yan, Meng-Qi; Xia, Chun-Li; Wang, Zhong-Hua*; Feng, Ying-Qing*Annals of Translational Medicine, 2022, 10(6).被引 6
